Benzoisoindole derivatives for the treatment of pain

Details for Australian Patent Application No. 2007211483 (hide)

Owner Glaxo Group Limited

Inventors Giblin, Gerard Martin Paul; Price, Helen Susanne; Healy, Mark Patrick

Agent Davies Collison Cave

Pub. Number AU-B-2007211483

PCT Pub. Number WO2007/088189

Priority 0615094.0 28.07.06 GB; 0602238.8 03.02.06 GB

Filing date 1 February 2007

Wipo publication date 9 August 2007

Acceptance publication date 16 August 2012

International Classifications

C07D 209/64 Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom

A61K 31/4035

A61P 25/02 Drugs for disorders of the nervous system

C07D 209/66 Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom

Event Publications

14 August 2008 PCT application entered the National Phase

  PCT publication WO2007/088189 Priority application(s): WO2007/088189

16 August 2012 Application Accepted

  Published as AU-B-2007211483

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007211484-Benzo (f) isoindol-2-ylphenyl acetic acid derivatives as EP4 receptor agonists

2007211475-Novel dual NK2/NK3-antagonists, pharmaceutical compositions comprising them and processes for their preparations